# Compound Preferred LLC – FDA Inspection, Aug 1, 2019

Source: https://www.keypedia.com/records/fda_inspections/compound-preferred-llc/9bc0090c-07a8-4563-8445-3b9bdcf35d19
Source feed: FDA_Inspections

> FDA inspection 1098749 of Compound Preferred LLC, August 01, 2019. 7 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1098749
- Company Name: Compound Preferred LLC
- Inspection Date: 2019-08-01
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Seattle District Office
- Citation Count: 7

## Related Documents

- [FDA Inspection 1159061 - 2021-12-17](https://www.keypedia.com/records/fda_inspections/compound-preferred-llc/f75dd550-8079-42cf-8722-8f6bebb8f4ba)
- [FDA Inspection 1005663 - 2017-03-01](https://www.keypedia.com/records/fda_inspections/compound-preferred-llc/c23faefa-7f51-4fa6-bb0f-e203e02d6580)

## Related Officers

- [Bryan L. Mcguckin](https://www.keypedia.com/people/bryan-l-mcguckin/33eaa16d-a642-4945-81f3-5d9ac180c2db)

Company: https://www.keypedia.com/companies/compound-preferred-llc/0137c1b7-e3ba-45ff-9fda-c53b21b0b857

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913